vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Cambium Networks Corp (CMBM). Click either name above to swap in a different company.

Cambium Networks Corp is the larger business by last-quarter revenue ($40.3M vs $23.1M, roughly 1.7× ADC Therapeutics SA). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -23.2%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -27.2%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Cambium Networks Corporation is an American manufacturer of wireless telecommunications equipment, including Enterprise WiFi, Network switch, Internet of Things, and fixed wireless broadband and Wi-Fi for enterprises products for Internet access. Publicly traded on the NASDAQ stock exchange, it spun out of Motorola in October 2011.

ADCT vs CMBM — Head-to-Head

Bigger by revenue
CMBM
CMBM
1.7× larger
CMBM
$40.3M
$23.1M
ADCT
Growing faster (revenue YoY)
ADCT
ADCT
+59.5% gap
ADCT
36.4%
-23.2%
CMBM
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
-27.2%
CMBM

Income Statement — Q4 FY2025 vs Q4 FY2024

Metric
ADCT
ADCT
CMBM
CMBM
Revenue
$23.1M
$40.3M
Net Profit
$-7.2M
Gross Margin
36.6%
Operating Margin
-77.7%
-28.4%
Net Margin
-17.9%
Revenue YoY
36.4%
-23.2%
Net Profit YoY
71.0%
EPS (diluted)
$0.04
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
CMBM
CMBM
Q4 25
$23.1M
Q3 25
$15.8M
Q2 25
$18.1M
Q1 25
$17.4M
Q4 24
$16.9M
$40.3M
Q3 24
$18.0M
$44.7M
Q2 24
$17.0M
$45.2M
Q1 24
$17.8M
$47.1M
Net Profit
ADCT
ADCT
CMBM
CMBM
Q4 25
Q3 25
$-41.0M
Q2 25
$-56.6M
Q1 25
$-38.6M
Q4 24
$-7.2M
Q3 24
$-44.0M
$-34.5M
Q2 24
$-36.5M
$-14.2M
Q1 24
$-46.6M
$-18.4M
Gross Margin
ADCT
ADCT
CMBM
CMBM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
36.6%
Q3 24
43.6%
Q2 24
32.5%
Q1 24
29.8%
Operating Margin
ADCT
ADCT
CMBM
CMBM
Q4 25
-77.7%
Q3 25
-196.6%
Q2 25
-244.1%
Q1 25
-163.5%
Q4 24
-191.8%
-28.4%
Q3 24
-197.4%
-69.6%
Q2 24
-170.5%
-27.2%
Q1 24
-188.3%
-33.1%
Net Margin
ADCT
ADCT
CMBM
CMBM
Q4 25
Q3 25
-260.1%
Q2 25
-313.2%
Q1 25
-221.8%
Q4 24
-17.9%
Q3 24
-244.1%
-77.3%
Q2 24
-214.6%
-31.5%
Q1 24
-261.1%
-39.2%
EPS (diluted)
ADCT
ADCT
CMBM
CMBM
Q4 25
$0.04
Q3 25
$-0.30
Q2 25
$-0.50
Q1 25
$-0.36
Q4 24
$-0.26
$-0.26
Q3 24
$-0.42
$-1.22
Q2 24
$-0.38
$-0.51
Q1 24
$-0.56
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
CMBM
CMBM
Cash + ST InvestmentsLiquidity on hand
$261.3M
Total DebtLower is stronger
$67.6M
Stockholders' EquityBook value
$-185.8M
$-3.2M
Total Assets
$323.1M
$173.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
CMBM
CMBM
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Q1 24
$234.3M
Total Debt
ADCT
ADCT
CMBM
CMBM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$67.6M
Q3 24
$67.6M
Q2 24
$68.9M
Q1 24
$63.8M
Stockholders' Equity
ADCT
ADCT
CMBM
CMBM
Q4 25
$-185.8M
Q3 25
$-238.2M
Q2 25
$-199.2M
Q1 25
$-238.2M
Q4 24
$-202.6M
$-3.2M
Q3 24
$-171.9M
$1.9M
Q2 24
$-131.7M
$34.1M
Q1 24
$-194.4M
$45.0M
Total Assets
ADCT
ADCT
CMBM
CMBM
Q4 25
$323.1M
Q3 25
$289.8M
Q2 25
$321.6M
Q1 25
$272.5M
Q4 24
$322.0M
$173.7M
Q3 24
$349.1M
$194.3M
Q2 24
$371.8M
$221.1M
Q1 24
$308.0M
$219.8M
Debt / Equity
ADCT
ADCT
CMBM
CMBM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
36.12×
Q2 24
2.02×
Q1 24
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
CMBM
CMBM
Operating Cash FlowLast quarter
$-31.1M
$-10.4M
Free Cash FlowOCF − Capex
$-10.8M
FCF MarginFCF / Revenue
-26.8%
Capex IntensityCapex / Revenue
0.0%
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
CMBM
CMBM
Q4 25
$-31.1M
Q3 25
$-29.6M
Q2 25
$-24.1M
Q1 25
$-56.3M
Q4 24
$-21.9M
$-10.4M
Q3 24
$-25.0M
$8.9M
Q2 24
$-32.8M
$2.4M
Q1 24
$-44.1M
$-15.9M
Free Cash Flow
ADCT
ADCT
CMBM
CMBM
Q4 25
Q3 25
Q2 25
Q1 25
$-56.6M
Q4 24
$-21.9M
$-10.8M
Q3 24
$-25.3M
$6.8M
Q2 24
$-32.9M
$87.0K
Q1 24
$-44.6M
$-17.4M
FCF Margin
ADCT
ADCT
CMBM
CMBM
Q4 25
Q3 25
Q2 25
Q1 25
-325.2%
Q4 24
-129.8%
-26.8%
Q3 24
-140.2%
15.2%
Q2 24
-193.0%
0.2%
Q1 24
-250.0%
-37.0%
Capex Intensity
ADCT
ADCT
CMBM
CMBM
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
Q4 24
0.5%
1.1%
Q3 24
1.2%
4.8%
Q2 24
0.2%
5.1%
Q1 24
3.0%
3.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

CMBM
CMBM

Enterprise$16.6M41%
Point To Multi Point$16.4M41%
Other$5.8M14%

Related Comparisons